Investment Rating - The report gives a "Buy" rating for the company [4][14]. Core Views - The company is a global leader in cement engineering, maintaining the largest market share in the cement engineering service market for 17 consecutive years. It has integrated high-quality resources in domestic cement industrial research, design, equipment, and engineering, making it the only company with a complete industrial chain in the global cement technology equipment and engineering service market [2][7]. - The company is actively pursuing a transformation towards equipment and operations, with significant growth in international business under its "Two Outs" strategy, which focuses on "cement outside" and "overseas" [2][7]. - The company has a strong outlook for future growth, with expected high dividend yields in 2025-2026, providing stable investment returns [2][7]. Summary by Sections Company Overview - Founded in 2001 and listed in 2005, the company has undertaken 364 production lines in 91 countries and regions as of H1 2025, with a market share of 54% in overseas revenue [2][7]. - The major revenue contributions in H1 2025 were from engineering technology services (58.46%), production operation services (28.99%), and high-end equipment manufacturing (10.73%) [2]. Financial Performance - The company expects revenue growth from 484.46 billion yuan in 2025 to 539.29 billion yuan in 2027, with a compound annual growth rate (CAGR) of approximately 5.03% to 5.58% [13][14]. - The projected net profit for 2025 is 31.40 billion yuan, increasing to 35.63 billion yuan by 2027, reflecting a growth rate of 5.25% to 6.76% [14][17]. Business Segments 1. **Engineering Technology Services** - Expected revenue of 276.68 billion yuan in 2025, with a stable growth rate of 2% annually [8][13]. - Anticipated gross margin of 16.00% in 2025 [8][13]. 2. **High-end Equipment Manufacturing** - Projected revenue of 65.87 billion yuan in 2025, with a growth rate of 6% [9][13]. - Expected gross margin of 23% [9][13]. 3. **Production Operation Services** - Expected revenue of 142.12 billion yuan in 2025, with a growth rate of 10% [11][13]. - Anticipated gross margin of 21.60% [11][13]. 4. **Other Businesses** - Projected revenue of 25.87 billion yuan in 2025, with a growth rate of 10% [12][13]. - Expected gross margin of 23.50% [12][13]. Valuation - The report estimates a target price of 11.89 yuan per share based on a 10x price-to-earnings (P/E) ratio for 2025 [14][15].

Group 1: Mona Lisa (002918) - The company's revenue from distribution channels decreased by 10% year-on-year, while the engineering channel saw a decline of 42.68% in the first half of 2025 [1] - Distribution accounted for 82.98% of revenue in Q2, with ongoing declines in engineering [1] - The company is focusing on cost reduction and efficiency improvements to cope with intense industry competition and is seeking a balance between volume and price [1] Group 2: Yuanjie Technology - The company experienced significant revenue growth in the data communication sector, particularly for 400G/800G optical modules, with an upward trend expected in the second half of 2025 [2] - Key products such as 100G PM4EML have passed customer validation, and the company is making core technological breakthroughs in high-power CW light sources and high-speed EML [2] - The U.S. factory is undergoing renovations and equipment procurement to support expansion, with ongoing investments in R&D to maintain high gross margins [2] Group 3: Obi Zhongguang - The company achieved a revenue of 435.47 million yuan in the first half of 2025, a year-on-year increase of 104.14%, with a net profit of 60.19 million yuan [3] - The company is accelerating its strategy of "technology innovation investment to commercial results transformation" and focusing on essential markets with new product launches [3] - Collaborations with companies like Cloudwalk Technology and NVIDIA are underway to enhance product offerings in robotics and 3D scanning [3] Group 4: Weisi Medical - The company's lower limb exoskeleton device has been included in the medical insurance directory, enhancing its market position [4] - The company offers electrical stimulation products primarily used in obstetrics and gynecology departments [4] Group 5: China National Materials International - The company is the only global enterprise with a complete industrial chain in cement technology equipment and engineering services [5] - Successful localization of DeepSeek has been completed, providing large model applications and opening enterprise knowledge base scenarios [5] Group 6: Dongfang Shenghong - The refining segment reported a net profit of 257 million yuan in the first half of 2025, marking a turnaround from losses [6] - The company is expected to benefit from anti-involution policies as a large-scale integrated refining enterprise [6] - Two 200,000-ton/year ethylene vinyl acetate (EV) plants have been commissioned, with a 100,000-ton POE plant expected to start production in Q3 2025 [6] Group 7: Ningbo Jingda - The company specializes in heat exchanger equipment and precision pressure machine equipment, focusing on battery shell and motor shell stamping equipment [7] - Despite a slight decline in performance due to international trade factors, there was a recovery in Q2 with double-digit growth in orders [7] - The acquisition of Wuxi Weiyan has led to a 70% increase in export orders, with North American orders reaching last year's total [7]

长江商报消息 ●长江商报记者 沈右荣 中国建材集团旗下的上市平台之一中材国际（600970.SH）又在海 外揽下一份大单。 8月15日晚间，中材国际发布公告，公司及境外子公司签下了一份总承包合同，合同额2.98亿美元，约 合人民币21.4亿元。 2025年上半年，中材国际新签合同额约为412亿元，同比增长11%。其中，境外新签合同额约为278亿 元，同比增长19%。 截至2025年6月30日，中材国际未完合同额约为620亿元，较今年一季度末增长5.94%。 中材国际深耕全球市场，且国内市场齐头并进。2024年，公司境内外市场收入占比分别为51.27%、 48.27%。 近年来，尽管全球市场复杂多变，但中材国际的经营业绩表现出了确定性。2021年至2024年，公司营收 净利连续4年双增。 科技创新能力是中材国际的核心竞争力，公司称，公司拥有全流程、全规模、高品质、成套高端水泥技 术装备研发制造能力，依托科研创新和海量应用场景，主要性能指标达到世界领先水平。 2024年，中材国际研发投入17.70亿元。 新签合同额继续稳增长 海外市场发力，中材国际再签一份大单。 根据公告，近日，公司及沙特子公司与卡西姆水泥公司（ ...

Macro Strategy - The report emphasizes that expanding consumer demand is more effective than capacity reduction policies in addressing low inflation, as service prices have dropped to historical lows, which is the core issue of the current price cycle [1][10] - If consumption policies are strengthened, service prices could rise by 2 percentage points, leading to a GDP deflator increase from -0.7% to +0.39%, which would be more beneficial than the effects of capacity reduction [1][10] - Historical comparisons indicate that the current price pressure is primarily demand-driven, with the second industry contributing only 48% to the current low inflation, significantly lower than previous years [1][10] Fixed Income Strategy - The report discusses the introduction of buying and selling government bonds as a new monetary policy tool in China, aimed at managing interest rate risks amid a declining yield environment [2][12] - It highlights that the People's Bank of China has primarily focused on buying government bonds to release liquidity, given the current low inflation environment [2][12] - The effectiveness of these operations will depend on the central bank's ability to provide clear forward guidance to shape market expectations [2][12] Company Analysis: Zhengfan Convertible Bonds - Zhengfan Convertible Bonds are expected to list at a price between 115.63 and 128.82 yuan, with a subscription rate of 0.0048% [3][15] - The bonds have a solid debt protection feature, with a conversion premium rate of approximately 25% anticipated on the first day of listing [3][15] - Zhengfan Technology has shown steady revenue growth, with a compound annual growth rate of 34.10% from 2019 to 2023, and a revenue of 38.35 billion yuan in 2023, reflecting a 41.78% year-on-year increase [3][15] Company Analysis: Kelun-Botai - Kelun-Botai's revenue for 2024 is projected at 19.3 billion yuan, a 25.5% increase year-on-year, with a gross profit of 12.74 billion yuan, up 67.8% [5][16] - The company is expected to see rapid growth in multiple products as they commercialize, with significant clinical data supporting their efficacy [5][16] - Revenue forecasts for 2025 and 2026 have been raised to 17.8 billion and 35.6 billion yuan, respectively, with an expected revenue of 58.9 billion yuan in 2027 [5][16] Company Analysis: China National Materials - China National Materials reported a total revenue of 461.27 billion yuan for 2024, a 0.7% increase, and a net profit of 29.83 billion yuan, up 2.3% [6][19] - The company has shown resilience in its Q4 performance, with overseas engineering and operation maintenance businesses performing well [6][19] - The company plans to distribute a cash dividend of 4.5 yuan per 10 shares, reflecting its commitment to shareholder returns [6][19]